Physician profile
Lige Kaplan
NPI 1780894949
$326,511.53
in general payments reported to CMS, 2019-2025
10 companies · $84K in 2025
The $84K reported for 2025 was more than what 91% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $29K · 2021: $13K · 2022: $52K · 2023: $89K · 2024: $42K · 2025: $84K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $167K · Travel and Lodging: $40K · Food and Beverage: $9,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $166,792.50 |
| Travel and Lodging | $40,204.64 |
| Food and Beverage | $9,076.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $321,611.39 | 2019-2025 | Mako, Insignia, Triathlon |
| Smith+Nephew, INC. | $1,822.91 | 2019-2025 | Real Intelligence, Or3o Dual Mobility, Legion |
| Depuy Synthes Sales INC. | $1,732.78 | 2019-2023 | Actis, Kincise, Emphasys |
| Abbott Laboratories | $527.48 | 2021-2025 | Eterna, Proclaim |
| Zimmer Biomet Holdings, INC. | $484.55 | 2019-2023 | Persona |
| Davol INC. | $143.30 | 2022 | |
| Pacira Therapeutics, INC. | $75.00 | 2019 | |
| Biocomposites INC | $64.28 | 2019 | |
| Baxter Healthcare | $36.71 | 2024 | Floseal |
| Medical Device Business Services, INC. | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lige Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.